0000912282-23-000586.txt : 20231226 0000912282-23-000586.hdr.sgml : 20231226 20231226200651 ACCESSION NUMBER: 0000912282-23-000586 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231215 FILED AS OF DATE: 20231226 DATE AS OF CHANGE: 20231226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VITA NICHOLAS CENTRAL INDEX KEY: 0001907623 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56294 FILM NUMBER: 231514407 MAIL ADDRESS: STREET 1: C/O COLUMBIA CARE INC. STREET 2: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cannabist Co Holdings Inc. CENTRAL INDEX KEY: 0001776738 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 981488978 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125543424 MAIL ADDRESS: STREET 1: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Columbia Care Inc. DATE OF NAME CHANGE: 20190514 4 1 form4.xml X0508 4 2023-12-15 0001776738 Cannabist Co Holdings Inc. CBSTF 0001907623 VITA NICHOLAS C/O THE CANNABIST COMPANY HOLDINGS INC. 680 FIFTH AVENUE, 24TH FLOOR NEW YORK NY 10019 true true Chief Executive Officer false Common Shares 2023-12-15 4 G 0 1000000 0 D 18727075 I Held by Vita Holdings LLC Common Shares 2023-12-20 4 S 0 100000 0.39 D 18627075 I Held by Vita Holdings LLC Common Shares 2023-12-21 4 S 0 300000 0.3756 D 18327075 I Held by Vita Holdings LLC Common Shares 2023-12-22 4 S 0 200000 0.3884 D 18127075 I Held by Vita Holdings LLC Common Shares 618950 I Held by Vita Holdings LLC Transaction represents contribution of shares by the Reporting Person for pediatric genetic and medical research for orphan and ultra rare illnesses, educational and other philanthropic purposes. The sales price reported above was converted from the Canadian sales price of $0.52 using an exchange rate of C$1.3331 = US$1.00. The sale price reported above was converted from the Canadian sale price of C$0.50 using an exchange rate of C$1.3311 = US$1.00. Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, education and philanthropic purposes. The sale price reported above was converted from the Canadian weighted average price of C$0.515 using an exchange rate of C$1.3258 = US$1.00. These shares were sold in multiple transactions at prices ranging from C$0.51 to C$0.52, inclusive. The Reporting Person undertakes to provide to The Cannabist Company Holdings Inc., any security holder of The Cannabist Company Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Nicholas Vita 2023-12-26